Global Shifts: Legal, Environmental, and Business Developments in Focus

The Financial Times reports on major developments: Merck Mercuriadis to step down from Hipgnosis, infrastructure improvement delays impact UK’s renewable energy transition, Moderna wins partial legal victory over its Covid-19 vaccine patent, and UK water companies face legal challenges following a landmark pollution ruling.

The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines

- Hipgnosis founder Merck Mercuriadis to step down after Blackstone deal - UK port owners warn infrastructure improvement delays threaten renewables shift

- Moderna secures partial victory in Covid vaccine legal fight - Water companies face legal challenges after landmark UK pollution ruling

Overview - Hipgnosis Song Management said its founder Merck Mercuriadis would step down as its chairman once the proposed acquisition of music investor Hipgnosis Songs Fund by a firm owned by Blackstone-managed funds gets completed.

- The UK's transition to renewable energy risks being held back by the lack of progress in infrastructure improvements due to the marine environment regulator's "unreasonable delays" in approvals, port leaders have warned. - Moderna has secured a partial victory in its intellectual property battle with Pfizer and BioNTech over the development of Covid-19 vaccines, after a London court found one of the US company's patents had been infringed.

- Water companies could face a series of legal challenges after a landmark judgment from the Supreme Court ruled that private landowners and individuals can seek redress for sewage released into UK waterways. (Compiled by Bengaluru newsroom)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)